FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:844-846 March 15, 2001 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Bozzette, S. A. Related Article by Freedberg, K. A. PubMed Citation

Dramatic declines in the incidence of AIDS and the number of deaths from this disease began in the United States in 1996, in association with the widespread use of potent combinations of antiretroviral drugs. Subsequently, the rates of decline have slowed and begun to level. As of June 2000, more than 300,000 people were estimated to be living with AIDS. Each year, there are about 40,000 new infections with the human immunodeficiency virus (HIV) and 16,000 deaths from AIDS. About one third of the 800,000 to 900,000 Americans estimated to be living with HIV or AIDS do not know they . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Gilden, D. E., Kubisiak, J. M., Gilden, D. M. (2007). Managing Medicare's HIV Caseload in the Era of Suppressive Therapy. Am. J. Public Health 97: 1053-1059 [Abstract] [Full Text]  
• Ingram, R. A. (2003). Counting the True Cost and Value of Medicines. The Oncologist 8: 2-4 [Full Text]  
• Steinbrook, R., Drazen, J. M. (2001). AIDS -- Will the Next 20 Years Be Different?. NEJM 344: 1781-1782 [Full Text]  
• (2001). Cost-Effectiveness of HIV Care. JWatch Infect. Diseases 2001: 4-4 [Full Text]